Publicaciones (47) Publicaciones en las que ha participado algún/a investigador/a

2012

  1. 5-fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer

    International Journal of Nanomedicine, Vol. 7, pp. 95-107

  2. A shorter and more specific oral sensitization-based experimental model of food allergy in mice

    Journal of Immunological Methods, Vol. 381, Núm. 1-2, pp. 41-49

  3. Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats

    Free Radical Biology and Medicine, Vol. 53, Núm. 4, pp. 730-741

  4. Actuaciones profesionales realizadas en la farmacia comunitaria

    Pharmaceutical care España, Vol. 14, Núm. 5, pp. 193-201

  5. Adecuación de la profilaxis antimicrobiana perioperatoria en apendicitis

    Atencion Farmaceutica, Vol. 14, Núm. 4, pp. 245-250

  6. Agreement Between Community Pharmacy and Ambulatory and Home Blood Pressure Measurement Methods to Assess the Effectiveness of Antihypertensive Treatment: The MEPAFAR Study

    Journal of Clinical Hypertension, Vol. 14, Núm. 4, pp. 236-244

  7. Agreement between community pharmacy, physician's office, and home blood pressure measurement Methods : the palmera study

    American Journal of Hypertension, Vol. 25, Núm. 3, pp. 290-296

  8. Common health problems management uncertainties in heart failure: A qualitative study

    Farmacia Hospitalaria, Vol. 36, Núm. 6, pp. 498-505

  9. Conocimiento sobre tabaco y sus método de deshabituación entre los estudiantes de 1º, 3º y 5º curso de Farmacia en España. Estudio PRECOTABAC. Parte II

    Ars pharmaceutica, Vol. 53, Núm. 4, pp. 8-15

  10. Current trend in pharmaceutical law in EU

    Pharmaceuticals Policy and Law, Vol. 14, Núm. 2-4, pp. 195-207

  11. Desarrollo y validación de un cuestionario de satisfacción de pacientes con el seguimiento farmacoterapéutico en farmacias comunitarias

    Revista de calidad asistencial, Vol. 27, Núm. 6, pp. 311-318

  12. Different cardiovascular protective effects of quercetin administered orally or intraperitoneally in spontaneously hypertensive rats

    Food and Function, Vol. 3, Núm. 6, pp. 643-650

  13. Doxorubicin-loaded nanoparticles: New advances in breast cancer therapy

    Anti-Cancer Agents in Medicinal Chemistry, Vol. 12, Núm. 9, pp. 1058-1070

  14. Drug delivery to inflammation based on nanoparticles surface decorated with biomolecules

    Current Medicinal Chemistry, Vol. 19, Núm. 19, pp. 3203-3211

  15. Drug targeting to cancer by nanoparticles surface functionalized with special biomolecules

    Current Medicinal Chemistry, Vol. 19, Núm. 19, pp. 3188-3195

  16. Efecto del seguimiento farmacoterapéutico en pacientes con hiperparatiroidismo secundario tratados con cinacalcet

    Farmacia Hospitalaria, Vol. 36, Núm. 5, pp. 321-327

  17. Effect of a pharmacist intervention in Spanish community pharmacies on blood pressure control in hypertensive patients

    American Journal of Health-System Pharmacy, Vol. 69, Núm. 15, pp. 1311-1318

  18. Effectiveness of the bevacizumab-irinotecan regimen in the treatment of recurrent glioblastoma multiforme: Comparison with other second-line treatments without this regimen

    Oncology Letters, Vol. 4, Núm. 5, pp. 1114-1118

  19. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension

    Free Radical Biology and Medicine, Vol. 52, Núm. 1, pp. 70-79

  20. Estudio de adecuación a la ficha técnica de las prescripciones de trastuzumab en un hospital de tercer nivel

    Farmacia Hospitalaria, Vol. 36, Núm. 3, pp. 135-140